.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Citi
Julphar
Fish and Richardson
Cerilliant
Express Scripts
Healthtrust
Moodys
Harvard Business School
Queensland Health

Generated: November 24, 2017

DrugPatentWatch Database Preview

Vansen Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for VANSEN PHARMA, and when can generic versions of VANSEN PHARMA drugs launch?

VANSEN PHARMA has one approved drug.

There is one US patent protecting VANSEN PHARMA drugs.

There are seventeen patent family members on VANSEN PHARMA drugs in fifteen countries.

Summary for Vansen Pharma

International Patents:17
US Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 2008DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001DISCNNoNo► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Vansen Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 2008► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-002Jul 21, 2008► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
Vansen Pharma
SPECTRACEF
cefditoren pivoxil
TABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Vansen Pharma Drugs

Country Document Number Estimated Expiration
European Patent Office0862915► Subscribe
Brazil9610836► Subscribe
Austria214930► Subscribe
Spain2174109► Subscribe
China1202110► Subscribe
Portugal862915► Subscribe
World Intellectual Property Organization (WIPO)9713516► Subscribe
Germany69620220► Subscribe
Argentina004014► Subscribe
Japan2831135► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Farmers Insurance
Merck
Queensland Health
Julphar
Daiichi Sankyo
Cantor Fitzgerald
AstraZeneca
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot